Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.59 |
| ▸ | HPGD | P15428 | 8/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.51 |
| ▸ | HKDC1 | Q2TB90 | 6/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 3/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4921409 | 0.85 | ALDH1A1 (0.57) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 | |
| SCHEMBL4914020 | 0.74 | ALDH1A1 (0.58) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 | |
| SCHEMBL4914572 | 0.71 | PDE4B (0.70) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 | |
| SCHEMBL4917120 | 0.69 | PDE4B (0.72) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 | |
| SCHEMBL4920370 | 0.68 | PDE4B (1.00) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 | |
| SCHEMBL4922646 | 0.68 | ALDH1A1 (0.56) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 | |
| SCHEMBL4709157 | 0.68 | KDM4E (0.75) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 | |
| SCHEMBL23378577 | 0.67 | ALDH1A1 (0.57) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 | |
| SCHEMBL30187832 | 0.66 | CHRM4 (0.65) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 | |
| SCHEMBL19741349 | 0.66 | CHRM4 (0.65) | ALDH1A1HSD17B10HPGDKDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080221096-A1 | Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives | LABORATORIOS ALMIRALL, S.A. (ES) | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221096-A1 | Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives | NR1H2, CBR3, NR4A1 | ALDH1A1 2625/4885HSD17B10 472/4885HPGD 1978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.